Tag: Group Leaders

Search News
Categories
Archives
Introducing Dr Özgen Deniz

21st December 2022

We are pleased to welcome Dr Özgen Deniz to Barts Cancer Institute (BCI) at Queen Mary University of London as a Lecturer and Group Leader. After receiving a Cancer Research UK Career Development Fellowship, Dr Deniz is establishing her own independent research group in BCI’s Centre for Haemato-Oncology.

Read more

Professor Victoria Sanz-Moreno recognised for major contributions in the fight against melanoma

17th October 2022

Congratulations to Professor Victoria Sanz-Moreno from Barts Cancer Institute at Queen Mary University of London who has received the Estela Medrano Memorial Award from the Society of Melanoma Research, which honours women who have made major contributions in the fight against melanoma.

Read more

Science and art collide at this year’s Royal Academy’s Summer Exhibition

21st June 2022

An artwork by Professor Tyson V. Sharp from Barts Cancer Institute at Queen Mary University of London has been selected for display in Room VIII at the Royal Academy of Art’s prestigious Summer Exhibition.

Read more

Investigating new treatment targets for lymphoma, and beyond

5th May 2022

We spoke with Dr John Riches, Clinical Senior Lecturer in the Centre for Haemato-Oncology at Barts Cancer Institute, Queen Mary University of London, about his team’s recent publication, which describes a new potential treatment target for a subset of lymphomas.

Read more

Prof Manchanda receives prestigious recognition from India’s leading medical school

17th March 2022

Congratulations to Professor Ranjit Manchanda from the CRUK Barts Centre who has been awarded the Distinguished Infosys Chair in Oncology at the All India Institute of Medical Sciences (AIIMS), New Delhi, India.

Read more

Tackling blood cancer with Blood Cancer UK

10th September 2021

This Blood Cancer Awareness Month, find out about the Blood Cancer UK-funded research projects currently underway at the Barts Cancer Institute, which span from looking at the specific genetic changes that drive blood cancer development, to identifying new treatment strategies to improve the outcomes for patients.

Read more

Search News
Categories
Archives